Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals Pickup As JPMorgan Event Kicks Off,” offering perspective ahead of the annual J.P. Morgan Healthcare Conference in San Francisco on capital-raising and mergers and acquisitions, in particular for the health care and life sciences sector.
“What a life sciences investor needs is a risk-on environment and a good portfolio of companies that have molecules that can go to market in the near term,” explained Lehot. “And that means they can be an acquisition target.”
(Subscription required)
People
Related News
31 March 2025
In the News
Louis Lehot Discusses the Current State of the IPO Market
Foley & Lardner LLP partner Louis Lehot was recently quoted in Barron's article, "The IPO Market and CoreWeave Sputter as Risk-Taking Wanes," where he discussed CoreWeave’s recent IPO and the current state of the IPO landscape.
28 March 2025
In the News
Louis Lehot Quoted in Law360 on CoreWeave IPO and 2025 IPO Outlook
Foley & Lardner LLP partner Louis Lehot was recently quoted in the Law360 article, "AI Startup CoreWeave's Tepid Debut Chills IPO Enthusiasm. "
27 March 2025
In the News
Vanessa Miller Weighs in on Trump Automotive Tariffs
Foley & Lardner LLP partner Vanessa Miller commented on the Trump administration's imposition of automotive tariffs in the Associated Press article, "Trump’s latest auto tariffs explained: What car buyers should know this year."